Bank of New York Mellon Corp Sells 27,560 Shares of Encompass Health Corporation $EHC

Bank of New York Mellon Corp lessened its stake in shares of Encompass Health Corporation (NYSE:EHC) by 2.7% during the third quarter, HoldingsChannel.com reports. The fund owned 1,011,179 shares of the company’s stock after selling 27,560 shares during the quarter. Bank of New York Mellon Corp’s holdings in Encompass Health were worth $128,440,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Royal Bank of Canada increased its stake in shares of Encompass Health by 21.5% in the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after buying an additional 25,574 shares in the last quarter. Caxton Associates LLP purchased a new position in shares of Encompass Health during the first quarter valued at about $259,000. Signaturefd LLC raised its holdings in shares of Encompass Health by 29.1% during the 2nd quarter. Signaturefd LLC now owns 869 shares of the company’s stock worth $107,000 after acquiring an additional 196 shares in the last quarter. Finally, Greenwood Capital Associates LLC bought a new position in Encompass Health during the second quarter valued at $215,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

EHC opened at $94.48 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The company has a market cap of $9.51 billion, a price-to-earnings ratio of 17.86, a PEG ratio of 1.52 and a beta of 0.74. The firm’s fifty day simple moving average is $106.05 and its two-hundred day simple moving average is $114.87.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the business earned $1.03 earnings per share. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. Equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Barclays lifted their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $142.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.